
Andrea Secades
Project Manager
Role
Degree
Ma in Project Management
Personal Info
ase@clinigma.com
About
Andrea brings over five years of hands-on experience managing international healthcare research projects, with particular expertise in patient engagement and qualitative study design.
Expertise
Pharmaceutical & Healthcare Research Management
- Extensive experience managing over 40 multi-country studies, including in-trial interviews, patient journey mapping, PRO development, and patient preference research
- Deep knowledge of therapeutic areas including oncology, rare diseases, autoimmune conditions, and cardiovascular health
- Trusted by clients for strategic input on study design, proposal development, and feasibility assessment
Stakeholder and Client Leadership
- Primary point of contact for sponsors, CROs, and internal teams across all project phases
- Skilled in navigating complex stakeholder environments, ensuring alignment between client expectations and operational delivery
- Delivered over 100 research proposals and supported bid-defence presentations and capability sessions across Europe
Operational Excellence in Qualitative Studies
- Manages project lifecycle from initiation to close-out, ensuring timelines, budgets, and compliance standards are met
- Experienced in setting up project teams, coordinating across functions, and standardising procedures for consistency across studies
- Proficient in managing simultaneous international projects while fostering team cohesion and quality delivery
Academic and Professional Credentials
- Master’s Degree in Project Management (VIU International University Valencia)
- University Degree in Advertising and Public Relations (Universidad Complutense Madrid)
- PMP- and Agile-informed approach to research operations and team leadership
Andrea’s combination of strategic insight, cultural fluency, and healthcare project management expertise makes her a vital part of CLINIGMA®’s team—ensuring that each patient interview study is delivered with precision, empathy, and regulatory confidence.